Veljan Denison Limited’s Board of Directors approved the adoption of a new Memorandum of Association (MOA) and Articles of Association (AOA) aligned with the Companies Act, 2013, during its meeting on August 3, 2026. The Board also sanctioned an alteration to Clause III(A) of the MOA by inserting Sub-Clause 5 to enable additional business activities incidental to future strategic plans. These changes require shareholder approval via Special Resolution at the upcoming Annual General Meeting (AGM).

The governance updates coincide with the company’s Q1FY27 financial results, which showed a 5% year-on-year rise in standalone net profit to ₹746.19 lakh. Consolidated net profit increased similarly to ₹767.79 lakh, while consolidated revenue grew 2% to ₹4,347.52 lakh. The Board recommended a dividend payment with a record date fixed for August 22, 2026. The AGM is scheduled for August 29, 2026, at the registered office in Hyderabad, where shareholders will vote on the constitutional document changes alongside other critical resolutions.

Governance and Corporate Actions

The existing MOA and AOA are based on the provisions of the Companies Act, 1956. The proposed adoption of new documents aims to align Veljan Denison’s constitutional framework with current regulatory requirements under the Companies Act, 2013 and associated rules. The alteration of the Main Objects Clause is intended to facilitate business expansion and diversification, allowing the company to pursue new opportunities in line with its growth strategy.

Key details of the proposed changes include:

The Board also approved the re-appointment of Dr. Suresh Akella as a Non-Executive Independent Director for a second five-year term, effective September 30, 2026. M/s. SRK & Co., Cost Accountants, was re-appointed as Cost Auditor for FY27. Remote e-voting will be scrutinized by Chakravarthy & Associates, Practicing Company Secretaries.

Financial Performance Highlights

Veljan Denison reported stable operations in its core Hydraulic Products segment. Standalone revenue from operations stood at ₹3,906.61 lakh, marginally up from ₹3,853.05 lakh in Q1FY26. Other income contributed ₹106.99 lakh, up from ₹67.36 lakh previously. Statutory Auditors Brahmayya & Co. issued an unmodified limited review report on both standalone and consolidated results, confirming compliance with Ind AS and SEBI Listing Regulations.

Consolidated expenses totaled ₹3,409.05 lakh, compared to ₹3,340.00 lakh in Q1FY26. Cost of materials consumed was ₹1,498.43 lakh, while employee benefit expenses rose to ₹521.39 lakh from ₹481.99 lakh. Finance costs decreased significantly to ₹13.47 lakh from ₹28.27 lakh in the prior year quarter, contributing to improved profitability margins.

What the Numbers Show

The decline in finance costs alongside stable revenue indicates improved capital efficiency in Q1FY27. While revenue growth remained modest at 1-2%, the 5% jump in net profit suggests effective cost management. The consolidation includes Adan Holdings Limited and Adan Limited, whose performance contributes to the group’s overall stability. The dividend recommendation signals management confidence in cash flows despite modest top-line growth. The simultaneous push for constitutional updates and business diversification hints at strategic preparation for future expansion beyond current hydraulic product offerings.

Veljan Denison Limited has approved the re-appointment of Dr. Suresh Akella as a Non-Executive Independent Director for a second consecutive term of five years, subject to shareholder approval. The Board of Directors made the decision at its meeting held on August 3, 2026, based on the recommendation of the Nomination and Remuneration Committee. The new term is scheduled to commence on September 30, 2026, and will run until September 29, 2031. This appointment ensures continuity in independent oversight for the Hyderabad-based manufacturing company.

The move follows a review of Dr. Akella’s qualifications, expertise, and experience in Manufacturing and FEM (Fabrication & Erection). The Board determined that his continued association remains beneficial to the Company’s strategic guidance and governance. The re-appointment must be ratified by shareholders through a Special Resolution. Until such approval is granted, the appointment remains conditional.

Appointment Details

The key parameters of the proposed re-appointment are outlined below:

Regulatory Compliance and Independence

The disclosure was made pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Company also cited compliance with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024. The Board confirmed that Dr. Akella satisfies the criteria of independence prescribed under the Companies Act, 2013 and the SEBI Listing Regulations.

Furthermore, the Company stated that Dr. Akella is not related to any other Director of the Company. He is also not debarred from holding the office of Director by virtue of any order passed by the Securities and Exchange Board of India or any other authority. The Nomination and Remuneration Committee recommended the re-appointment after verifying these independence criteria.

Profile and Expertise

Dr. Suresh Akella brings extensive experience in the Manufacturing and FEM sectors to the Board. His profile highlights significant expertise in technology and industry applications. The Board noted his valuable contributions through strategic guidance and independent oversight during his previous term. This background aligns with the Company’s operational focus and governance requirements for its independent directorship roles.